Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$257M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$254M |
| 3 |
Microsoft
MSFT
|
+$247M |
| 4 |
AerCap
AER
|
+$77.8M |
| 5 |
ON Semiconductor
ON
|
+$61.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Advanced Micro Devices
AMD
|
+$76.2M |
| 2 |
Diamondback Energy
FANG
|
+$44.8M |
| 3 |
Exelon
EXC
|
+$41.9M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$38.8M |
| 5 |
American Electric Power
AEP
|
+$38.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.23% |
| 2 | Consumer Discretionary | 11.75% |
| 3 | Industrials | 11.23% |
| 4 | Financials | 8.63% |
| 5 | Healthcare | 6.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Prospect Capital
PSEC
$1.16B
| $180K | ﹤0.01% |
+21,364
| New | +$180K |
|
1852
Banco de Chile
BCH
$21.7B
| $176K | ﹤0.01% |
+11,196
| New | +$199K |
|
1853
PUT
Quad
QUAD
$528M
| $176K | ﹤0.01% |
44,100
| – | – |
|
1854
Vera Bradley
VRA
$90.1M
| $176K | ﹤0.01% |
+20,632
| New | +$199K |
|
1855
ESS Tech
GWH
$12.8M
| $174K | ﹤0.01% |
+1,013
| New | +$224K |
|
|
CCC
1856
CCC Intelligent Solutions
CCC
$4.42B
| $173K | ﹤0.01% |
+15,230
| New | +$178K |
|
|
TCRR
1857
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
| $173K | ﹤0.01% |
37,024
-28,384
| -43% | -$177K |
|
|
ATIP
1858
DELISTED
ATI Physical Therapy, Inc.
ATIP
| $172K | ﹤0.01% |
+1,017
| New | +$171K |
|
1859
Veru
VERU
$44.2M
| $171K | ﹤0.01% |
2,902
-496
| -15% | -$37.9K |
|
1860
Hyliion Holdings
HYLN
$563M
| $169K | ﹤0.01% |
+27,330
| New | +$195K |
|
1861
Passage Bio
PASG
$14.5M
| $169K | ﹤0.01% |
1,330
-90
| -6% | -$14.7K |
|
1862
Destination XL Group
DXLG
$35.2M
| $167K | ﹤0.01% |
+29,344
| New | +$198K |
|
1863
Senseonics Holdings Inc
SENS
$496M
| $165K | ﹤0.01% |
+3,091
| New | +$201K |
|
1864
KRONOS Worldwide
KRO
$1B
| $164K | ﹤0.01% |
10,912
+297
| +3% | +$4.15K |
|
|
FMTX
1865
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
| $164K | ﹤0.01% |
11,563
-10,664
| -48% | -$185K |
|
|
DAO
1866
Youdao
DAO
$2.02B
| $162K | ﹤0.01% |
+12,987
| New | +$169K |
|
1867
First Bancorp
FBP
$4.31B
| $162K | ﹤0.01% |
11,791
-74,400
| -86% | -$1.02M |
|
1868
YPF Sociedad Anonima ADS
YPF
$20.1B
| $162K | ﹤0.01% |
42,475
+10,681
| +34% | +$44.8K |
|
1869
IHS Holding
IHS
$2.81B
| $161K | ﹤0.01% |
+11,385
| New | +$171K |
|
|
NKLA
1870
DELISTED
Nikola Corporation Common Stock
NKLA
| $161K | ﹤0.01% |
+544
| New | +$181K |
|
1871
Omeros
OMER
$1.4B
| $160K | ﹤0.01% |
24,936
-20,046
| -45% | -$145K |
|
|
HLTH
1872
DELISTED
Cue Health Inc. Common Stock
HLTH
| $160K | ﹤0.01% |
11,944
-556
| -4% | -$6.12K |
|
|
EXPR
1873
DELISTED
Express, Inc.
EXPR
| $159K | ﹤0.01% |
2,575
-2,406
| -48% | -$189K |
|
1874
PAVmed
PAVM
$40.8M
| $158K | ﹤0.01% |
+142
| New | +$309K |
|
1875
Transportadora de Gas del Sur
TGS
$4.29B
| $157K | ﹤0.01% |
+35,460
| New | +$178K |
|
Similar funds
Michael Gelband's Q4 2021 Portfolio in Review
As of Q4 2021, Michael Gelband held 2,843 positions worth $9.67B, up 30% from $7.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Michael Gelband deployed $1.95B of net new capital in Q4 2021, opening 810 new positions and adding to 656 existing holdings. Its largest new stake was Amazon: 1,500,500 shares worth $250M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Advanced Micro Devices, an estimated $76.2M trimmed.
- Michael Gelband's largest Q4 2021 buy was Amazon: 1,500,500 shares worth $250M.
- Michael Gelband added most to State Street SPDR S&P 500 ETF Trust in Q4 2021, an estimated $254M increase.
- Michael Gelband's biggest Q4 2021 reduction was Advanced Micro Devices, cutting an estimated $76.2M.
- Michael Gelband fully exited Diamondback Energy in Q4 2021, selling an estimated $44.8M.
- Michael Gelband's ten largest holdings make up 22% of its $9.67B portfolio in Q4 2021.
- Michael Gelband opened 810 new positions and closed 731 in Q4 2021.
- Michael Gelband's portfolio value rose 30% quarter-over-quarter to $9.67B.
Based on ExodusPoint Capital Management's 13F filing for Q4 2021, filed 11 Feb 2022.